Drug Evaluation in Atherosclerotic Vascular Disease in Diabetics - DAVID – (Picotamide vs. Aspirin)

Description:

The goal of the trial was to evaluate treatment with picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, compared with aspirin among diabetic patients with peripheral arterial disease (PAD).